Key Record Dates
ClinicalTrials.gov Identifier: | NCT05973773 |
---|---|
Brief Title: | REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors) (REZILIENT3) |
First Submitted : | July 11, 2023 |
First Submitted that Met QC Criteria : | July 25, 2023 |
First Posted : | August 3, 2023 |
Last Update Submitted that Met QC Criteria : | May 2, 2024 |
Last Update Posted : | May 3, 2024 |